The Chromatin, Topological and Regulatory Properties of Pluripotency-Associated Poised Enhancers Are Conserved in Vivo
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
The Structural Basis for Selective Binding of Non-Methylated Cpg Islands by the CFP1 CXXC Domain
ARTICLE Received 13 Dec 2010 | Accepted 9 Feb 2011 | Published 8 Mar 2011 DOI: 10.1038/ncomms1237 The structural basis for selective binding of non-methylated CpG islands by the CFP1 CXXC domain Chao Xu1,*, Chuanbing Bian1,*, Robert Lam1, Aiping Dong1 & Jinrong Min1,2 CFP1 is a CXXC domain-containing protein and an essential component of the SETD1 histone H3K4 methyltransferase complex. CXXC domain proteins direct different chromatin-modifying activities to various chromatin regions. Here, we report crystal structures of the CFP1 CXXC domain in complex with six different CpG DNA sequences. The crescent-shaped CFP1 CXXC domain is wedged into the major groove of the CpG DNA, distorting the B-form DNA, and interacts extensively with the major groove of the DNA. The structures elucidate the molecular mechanism of the non-methylated CpG-binding specificity of the CFP1 CXXC domain. The CpG motif is confined by a tripeptide located in a rigid loop, which only allows the accommodation of the non-methylated CpG dinucleotide. Furthermore, we demonstrate that CFP1 has a preference for a guanosine nucleotide following the CpG motif. 1 Structural Genomics Consortium, University of Toronto, 101 College Street, Toronto, Ontario M5G 1L7, Canada. 2 Department of Physiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada. *These authors contributed equally to this work. Correspondence and requests for materials should be addressed to J.M. (email: [email protected]). NATURE COMMUNICATIONS | 2:227 | DOI: 10.1038/ncomms1237 | www.nature.com/naturecommunications © 2011 Macmillan Publishers Limited. All rights reserved. ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms1237 pG islands contain a high density of CpG content and embrace the promoters of most genes in vertebrate genomes1. -
Protein Interactions in the Cancer Proteome† Cite This: Mol
Molecular BioSystems View Article Online PAPER View Journal | View Issue Small-molecule binding sites to explore protein– protein interactions in the cancer proteome† Cite this: Mol. BioSyst., 2016, 12,3067 David Xu,ab Shadia I. Jalal,c George W. Sledge Jr.d and Samy O. Meroueh*aef The Cancer Genome Atlas (TCGA) offers an unprecedented opportunity to identify small-molecule binding sites on proteins with overexpressed mRNA levels that correlate with poor survival. Here, we analyze RNA-seq and clinical data for 10 tumor types to identify genes that are both overexpressed and correlate with patient survival. Protein products of these genes were scanned for binding sites that possess shape and physicochemical properties that can accommodate small-molecule probes or therapeutic agents (druggable). These binding sites were classified as enzyme active sites (ENZ), protein–protein interaction sites (PPI), or other sites whose function is unknown (OTH). Interestingly, the overwhelming majority of binding sites were classified as OTH. We find that ENZ, PPI, and OTH binding sites often occurred on the same structure suggesting that many of these OTH cavities can be used for allosteric modulation of Creative Commons Attribution 3.0 Unported Licence. enzyme activity or protein–protein interactions with small molecules. We discovered several ENZ (PYCR1, QPRT,andHSPA6)andPPI(CASC5, ZBTB32,andCSAD) binding sites on proteins that have been seldom explored in cancer. We also found proteins that have been extensively studied in cancer that have not been previously explored with small molecules that harbor ENZ (PKMYT1, STEAP3,andNNMT) and PPI (HNF4A, MEF2B,andCBX2) binding sites. All binding sites were classified by the signaling pathways to Received 29th March 2016, which the protein that harbors them belongs using KEGG. -
Mouse Cbx2 Knockout Project (CRISPR/Cas9)
https://www.alphaknockout.com Mouse Cbx2 Knockout Project (CRISPR/Cas9) Objective: To create a Cbx2 knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Cbx2 gene (NCBI Reference Sequence: NM_007623 ; Ensembl: ENSMUSG00000025577 ) is located on Mouse chromosome 11. 5 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 5 (Transcript: ENSMUST00000026662). Exon 4 will be selected as target site. Cas9 and gRNA will be co-injected into fertilized eggs for KO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Mutations cause malformations of the axial skeletal, reduced viability, poor growth and male to female sex reversal. Exon 4 starts from about 11.75% of the coding region. Exon 4 covers 6.81% of the coding region. The size of effective KO region: ~106 bp. The KO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 4 5 Legends Exon of mouse Cbx2 Knockout region Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot (up) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 2000 bp section upstream of Exon 4 is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the Dot Plot (down) Window size: 15 bp Forward Reverse Complement Sequence 12 Note: The 1343 bp section downstream of Exon 4 is aligned with itself to determine if there are tandem repeats. -
Protein Quality Control in the Nucleolus Safeguards Recovery of Epigenetic
RESEARCH ARTICLE Protein quality control in the nucleolus safeguards recovery of epigenetic regulators after heat shock Maria Azkanaz1, Aida Rodrı´guezLo´ pez1, Bauke de Boer1, Wouter Huiting2, Pierre-Olivier Angrand3, Edo Vellenga1, Harm H Kampinga2, Steven Bergink2, Joost HA Martens4, Jan Jacob Schuringa1†, Vincent van den Boom1†* 1Department of Experimental Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; 2Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; 3Cell Plasticity & Cancer, Inserm U908, University of Lille, Lille, France; 4Department of Molecular Biology, Faculty of Science and Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, Netherlands Abstract Maintenance of epigenetic modifiers is of utmost importance to preserve the epigenome and consequently appropriate cellular functioning. Here, we analyzed Polycomb group protein (PcG) complex integrity in response to heat shock (HS). Upon HS, various Polycomb Repressive Complex (PRC)1 and PRC2 subunits, including CBX proteins, but also other chromatin regulators, are found to accumulate in the nucleolus. In parallel, binding of PRC1/2 to target genes is strongly reduced, coinciding with a dramatic loss of H2AK119ub and H3K27me3 marks. Nucleolar-accumulated CBX proteins are immobile, but remarkably both CBX protein accumulation and loss of PRC1/2 epigenetic marks are reversible. This post-heat shock recovery of pan-nuclear CBX protein localization and reinstallation of epigenetic marks is HSP70 dependent. Our findings *For correspondence: demonstrate that the nucleolus is an essential protein quality control center, which is indispensable [email protected] for recovery of epigenetic regulators and maintenance of the epigenome after heat shock. -
The Histone Demethylase KDM2B Regulates Human Primordial Germ
Int. J. Biol. Sci. 2021, Vol. 17 527 Ivyspring International Publisher International Journal of Biological Sciences 2021; 17(2): 527-538. doi: 10.7150/ijbs.55873 Research Paper The histone demethylase KDM2B regulates human primordial germ cell-like cells specification Weiyan Yuan1,#, Zhaokai Yao1,#, Veeramohan Veerapandian1,2,#, Xinyan Yang1, Xiaoman Wang1,3, Dingyao Chen1, Linzi Ma1, Chaohui Li1,2, Yi Zheng1, Fang Luo1, Xiao-yang Zhao1,4,5,6,7 1. State Key Laboratory of Organ Failure Research, Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China 2. Shunde Hospital of Southern Medical University, Shunde, Guangdong, China 3. Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China 4. Bioland Laboratory (Guangzhou Regenerative Medicine and Health Guangdong Laboratory), Guangzhou, China 5. Sino-America Joint Research Center for Translational Medicine in Developmental Disabilities 6. Department of Gynecology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China 7. National Clinical Research Center for Kidney Disease, Guangzhou, China # These authors contributed equally to this study Corresponding authors: Fang Luo ([email protected]), Xiao-Yang Zhao ([email protected]) © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. Received: 2020.11.13; Accepted: 2020.12.12; Published: 2021.01.01 Abstract Germline specification is a fundamental step for human reproduction and this biological phenomenon possesses technical challenges to study in vivo as it occurs immediately after blastocyst implantation. The establishment of in vitro human primordial germ cell-like cells (hPGCLCs) induction system allows sophisticated characterization of human primordial germ cells (hPGCs) development. -
An Atypical 12Q24.31 Microdeletion Implicates Six Genes Including A
Hum Genet DOI 10.1007/s00439-016-1668-4 ORIGINAL INVESTIGATION An atypical 12q24.31 microdeletion implicates six genes including a histone demethylase KDM2B and a histone methyltransferase SETD1B in syndromic intellectual disability Jonathan D. J. Labonne1,2 · Kang‑Han Lee3 · Shigeki Iwase4 · Il‑Keun Kong5 · Michael P. Diamond1 · Lawrence C. Layman1,2,6 · Cheol‑Hee Kim3 · Hyung‑Goo Kim1,2 Received: 13 November 2015 / Accepted: 31 March 2016 © Springer-Verlag Berlin Heidelberg 2016 Abstract Microdeletion syndromes are frequent causes by synteny analysis revealing the conservation of the order of neuropsychiatric disorders leading to intellectual dis- of these six candidate genes between humans and zebrafish. ability as well as autistic features accompanied by epilepsy Among them, we propose histone demethylase KDM2B and craniofacial anomalies. From comparative deletion and histone methyltransferase SETD1B as the two most mapping of the smallest microdeletion to date at 12q24.31, plausible candidate genes involved in intellectual disabil- found in a patient with overlapping clinical features of ity, autism, epilepsy, and craniofacial anomalies. These two 12q24.31 microdeletion syndrome, we narrowed the puta- chromatin modifiers located approximately 224 kb apart tive critical region to 445 kb containing seven genes, one were both commonly deleted in six patients, while two microRNA, and one non-coding RNA. Zebrafish in situ additional patients had either KDM2B or SETD1B deleted. hybridization and comprehensive transcript analysis of The four additional candidate genes (ORAI1, MORN3, annotated genes in the panels of human organ and brain TMEM120B, RHOF), a microRNA MIR548AQ, and a non- suggest that these are all candidates for neurological phe- coding RNA LINC01089 are localized between KDM2B notypes excluding the gene HPD. -
Evolutionarily Ancient BAH–PHD Protein Mediates Polycomb Silencing
Evolutionarily ancient BAH–PHD protein mediates Polycomb silencing Elizabeth T. Wilesa,1, Kevin J. McNaughta,1, Gurmeet Kaurb, Jeanne M. L. Selkera, Tereza Ormsbya,2, L. Aravindb, and Eric U. Selkera,3 aInstitute of Molecular Biology, University of Oregon, Eugene, OR 97403; and bNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894 Contributed by Eric U. Selker, March 18, 2020 (sent for review October 28, 2019; reviewed by Wolfgang Fischle and Steve Jacobsen) Methylation of histone H3 lysine 27 (H3K27) is widely recognized (NCU07505) that we show is critical for H3K27 methylation- as a transcriptionally repressive chromatin modification but the mediated silencing and therefore named it effector of Polycomb re- mechanism of repression remains unclear. We devised and imple- pression 1 (epr-1). It encodes a protein with a bromo-adjacent ho- mented a forward genetic scheme to identify factors required for mology (BAH) domain and plant homeodomain (PHD) finger. H3K27 methylation-mediated silencing in the filamentous fungus Although epr-1 mutants display phenotypic and gene-expression Neurospora crassa and identified a bromo-adjacent homology changes similar to strains lacking PRC2 components, H3K27 meth- (BAH)-plant homeodomain (PHD)-containing protein, EPR-1 (effec- ylation is essentially unaffected. We demonstrate that EPR-1 forms tor of polycomb repression 1; NCU07505). EPR-1 associates with nuclear foci, reminiscent of Polycomb bodies (24), and its genomic H3K27-methylated chromatin, and loss of EPR-1 de-represses H3K27- distribution is limited to, and dependent upon, H3K27-methylated methylated genes without loss of H3K27 methylation. EPR-1 is not chromatin, which may be recognized through its BAH domain. -
Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development
International Journal of Molecular Sciences Article Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development Nashwa El Hadidy 1 and Vladimir N. Uversky 1,2,* 1 Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd. MDC07, Tampa, FL 33612, USA; [email protected] 2 Laboratory of New Methods in Biology, Institute for Biological Instrumentation of the Russian Academy of Sciences, Federal Research Center “Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences”, Pushchino, 142290 Moscow Region, Russia * Correspondence: [email protected]; Tel.: +1-813-974-5816; Fax: +1-813-974-7357 Received: 20 September 2019; Accepted: 21 October 2019; Published: 23 October 2019 Abstract: The two-meter-long DNA is compressed into chromatin in the nucleus of every cell, which serves as a significant barrier to transcription. Therefore, for processes such as replication and transcription to occur, the highly compacted chromatin must be relaxed, and the processes required for chromatin reorganization for the aim of replication or transcription are controlled by ATP-dependent nucleosome remodelers. One of the most highly studied remodelers of this kind is the BRG1- or BRM-associated factor complex (BAF complex, also known as SWItch/sucrose non-fermentable (SWI/SNF) complex), which is crucial for the regulation of gene expression and differentiation in eukaryotes. Chromatin remodeling complex BAF is characterized by a highly polymorphic structure, containing from four to 17 subunits encoded by 29 genes. The aim of this paper is to provide an overview of the role of BAF complex in chromatin remodeling and also to use literature mining and a set of computational and bioinformatics tools to analyze structural properties, intrinsic disorder predisposition, and functionalities of its subunits, along with the description of the relations of different BAF complex subunits to the pathogenesis of various human diseases. -
X- and Y-Linked Chromatin-Modifying Genes As Regulators of Sex-Specific Cancer Incidence and Prognosis
Author Manuscript Published OnlineFirst on July 30, 2020; DOI: 10.1158/1078-0432.CCR-20-1741 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. X- and Y-linked chromatin-modifying genes as regulators of sex- specific cancer incidence and prognosis Rossella Tricarico1,2,*, Emmanuelle Nicolas1, Michael J. Hall 3, and Erica A. Golemis1,* 1Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA; 2Department of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy; 3Cancer Prevention and Control Program, Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA Running title: Allosomally linked epigenetic regulators in cancer Conflict Statement: The authors declare no conflict of interest. Funding: The authors are supported by NIH DK108195 and CA228187 (to EAG), by NCI Core Grant CA006927 (to Fox Chase Cancer Center), and by a Marie Curie Individual Fellowship from the Horizon 2020 EU Program (to RT). * Correspondence should be directed to: Erica A. Golemis Fox Chase Cancer Center 333 Cottman Ave. Philadelphia, PA 19111 USA [email protected] (215) 728-2860 or Rossella Tricarico Department of Biology and Biotechnology University of Pavia Via Ferrata 9, 27100 Pavia, Italy [email protected] +39 340-2429631 1 Downloaded from clincancerres.aacrjournals.org on September 25, 2021. © 2020 American Association for Cancer Research. Author Manuscript Published OnlineFirst on July 30, 2020; DOI: 10.1158/1078-0432.CCR-20-1741 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Abstract Biological sex profoundly conditions organismal development and physiology, imposing wide-ranging effects on cell signaling, metabolism, and immune response. -
RYBP-PRC1 Complexes Mediate H2A Ubiquitylation at Polycomb Target Sites Independently of PRC2 and H3k27me3
RYBP-PRC1 Complexes Mediate H2A Ubiquitylation at Polycomb Target Sites Independently of PRC2 and H3K27me3 Lı´gia Tavares,1 Emilia Dimitrova,2 David Oxley,3 Judith Webster,3 Raymond Poot,4 Jeroen Demmers,5 Karel Bezstarosti,5 Stephen Taylor,6 Hiroki Ura,7 Hiroshi Koide,7 Anton Wutz,8 Miguel Vidal,9 Sarah Elderkin,2,* and Neil Brockdorff1,* 1Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK 2Nuclear Dynamics 3Mass Spectrometry Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK 4Department of Cell Biology 5Proteomics Center Erasmus Medical Center, Dr. Molewaterplein 50, 3015GE Rotterdam, The Netherlands 6Computational Biology Research Group, WIMM, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UK 7Department of Stem Cell Biology, Graduate School of Medical Science, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8640, Japan 8Wellcome Trust Centre for Stem Cell Research, Tennis Court Road, Cambridge CB2 1QR, UK 9Cell Proliferation and Development, Centro de Investigaciones Biolo´ gicas, Consejo Superior de Investigaciones Cientificas (CSIC), 28040 Madrid, Spain *Correspondence: [email protected] (S.E.), [email protected] (N.B.) DOI 10.1016/j.cell.2011.12.029 SUMMARY histone-modifying activity critical for their function in gene re- pression, monoubiquitylation of histone H2AK119 (H2AK119u1), Polycomb-repressive complex 1 (PRC1) has a central and di- tri-methylation of histone H3K27, respectively (reviewed role in the regulation of heritable gene silencing in Mu¨ ller and Verrijzer, 2009). Mechanisms other than H2A during differentiation and development. PRC1 re- ubiquitylation also contribute to PRC1-mediated gene repression cruitment is generally attributed to interaction of (Eskeland et al., 2010; Francis et al., 2001, 2004; King et al., 2002; the chromodomain of the core protein Polycomb Shao et al., 1999). -
Anti-KDM2B (Aa 1274-1336) Polyclonal Antibody (DPABH-00578) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
Anti-KDM2B (aa 1274-1336) polyclonal antibody (DPABH-00578) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Antigen Description Histone demethylase that demethylates Lys-4 and Lys-36 of histone H3, thereby playing a central role in histone code. Preferentially demethylates trimethylated H3 Lys-4 and dimethylated H3 Lys-36 residue while it has weak or no activity for mono- and tri-methylated H3 Lys-36. Preferentially binds the transcribed region of ribosomal RNA and represses the transcription of ribosomal RNA genes which inhibits cell growth and proliferation. May also serve as a substrate- recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Immunogen Synthetic peptide, corresponding to a region within C terminal amino acids 1274-1336 of Human KDM2B. Isotype IgG Source/Host Rabbit Species Reactivity Mouse, Human Purification Immunogen affinity purified Conjugate Unconjugated Applications WB Format Liquid Size 50 μl Buffer pH: 7.00; Constituents: 89% PBS, 10% Glycerol Preservative None Storage Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. GENE INFORMATION Gene Name KDM2B lysine (K)-specific demethylase 2B [ Homo sapiens ] Official Symbol KDM2B 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved Synonyms KDM2B; lysine (K)-specific demethylase 2B; F box and leucine rich repeat protein 10; FBXL10; lysine-specific demethylase -
Investigating the Role of CBX2 in ER- Positive Breast Cancer
Investigating the role of CBX2 in ER- positive breast cancer Ella Jane Waters 201501212 MSc by Research Supervisor: Dr Mark Wade Second Supervisor: Dr Cheryl Walter Date: 24/09/2019 Faculty of Health Science Acknowledgements I would like to thank Dr Mark Wade for facilitating this project, being a great supervisor and for his continued guidance and support throughout. I would also like to thank Dr Cheryl Walter for the additional and valuable assistance, and for her kind words and support. Additionally, I would like to thank Chloe Warren for her continued encouragement and help in the laboratory. I would also like to thank Mrs Kath Bulmer, Dr Pedro Beltran-Alvarez and Dr Barbara Guinn for their knowledge and experience. I finally want to thank my family and friends for their patience and support throughout this year. i Abstract Breast cancer is the most common form of cancer in women, with oestrogen receptor (ER) positive breast cancers being the most common subtype. Although there are targeted endocrine therapies for this receptor, resistance mechanisms mean that they are not always effective. Post-translational modifications of histone proteins are important for regulating gene expression. It is known that the pattern of modifications is different in cancerous tissue compared to normal tissue. Epigenetic reader proteins recognise histone post-translational modifications and help remodel the adjacent chromatin landscape, resulting in gene expression or repression. This means epigenetic reader proteins are possible novel therapeutic targets. CBX2 is an example of an epigenetic reader protein which is overexpressed in ER-positive breast cancer. The aim of this study was to analyse the role of CBX2 in ER-positive breast cancer.